Sep 11,2024
Breast cancer remains the most prevalent cancer among women in India, constituting 14% of all female cancers. According to Dr. Sewanti Limaye, Director of Medical & Precision Oncology, Sir H. N. Reliance Foundation Hospital, approximately 178,000 new cases and 90,000 deaths were reported in 2020. The incidence of breast cancer is higher in urban areas due to lifestyle factors, with early detection being a significant challenge. Many cases are diagnosed at advanced stages, contributing to lower survival rates than in Western countries. Dr Limaye highlights that factors such as limited awareness, delayed diagnosis, and insufficient treatment facilities further exacerbate the issue, emphasizing the need to improve screening, public awareness, and healthcare infrastructure to reduce mortality rates.
Genetic factors are implicated in 5-10% of breast cancer cases, primarily due to BRCA1 and BRCA2 gene mutations. Women with these mutations are at significantly higher risk of developing breast cancer. Regular screening methods, including mammograms and clinical breast exams, are crucial, especially for women over 40 or those with a family history of the disease.
Multidisciplinary Approach to Treatment
In India, breast cancer treatment follows a multidisciplinary approach, explains Dr Limaye. After diagnosis through imaging and biopsy, treatment is tailored based on the cancer stage. For early-stage cancers, surgery—either a lumpectomy or mastectomy—is often followed by radiation therapy. More advanced cases may require pre-surgery treatments like chemotherapy, targeted therapy, immunotherapy, or hormonal therapy. Treatment after surgery aims to prevent recurrence. For Triple Negative Breast Cancer (TNBC), a combination of chemotherapy, immunotherapy, surgery, and radiation is typically employed. Treatment plans are highly personalized, taking into account tumor characteristics, the patient’s overall health, and resource availability. Access to personalized treatments and clinical trials is improving, especially in urban centers.
Side Effects and Mucositis Risk
Treatment for breast cancer can lead to several side effects, including pain, swelling, hair loss, fatigue, anemia, and, notably, mucositis. Mucositis, which affects 15-20% of patients undergoing chemotherapy, causes inflammation and ulceration of mucous membranes, particularly in the mouth and digestive tract. This can result in painful sores, making it difficult to eat and affecting overall nutrition and quality of life. Dr. Limaye underscores the importance of managing these side effects, as mucositis can necessitate dose adjustments or treatment breaks in chemotherapy.
Effective management of mucositis includes maintaining oral hygiene, pain relief measures, and the use of protective rinses. Severe cases may require more intensive interventions.
Dr. Sacheev Nanda, Chief Dental Surgeon and Prosthodontist, Ruby Hall Clinic, Pune, elaborates on the strategies for managing mucositis in cancer patients, which can significantly alleviate symptoms and improve quality of life. He recommends the following key approaches:
Complementary therapies like acupuncture or hypnosis can provide symptom relief. Psychological support may help with emotional well-being.
As of 2024, advances in targeted therapies, immunotherapy, and personalized medicine have significantly improved survival rates and patient quality of life. According to Dr. Limaye, early detection, combined with innovative treatments, is extending life expectancy for breast cancer patients. Meanwhile, effective management of side effects, such as mucositis, plays a critical role in reducing the overall treatment burden, enhancing patient outcomes.
Both Dr Limaye and Dr Nanda stress the importance of personalized, multidisciplinary care in managing breast cancer and its associated side effects, ensuring that patients receive the best possible treatment and support throughout their journey.